EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 26-Oct-2026 20:16 ET (27-Oct-2026 00:16 GMT/UTC)

Can mini organs help predict breast tumors’ response to therapy

University of California San Francisco Medical Center
Peer-Reviewed Publication

In a study in Cell Reports Medicine, UCSF researchers found that organoids were able to mimic a tumor’s response to treatment. They demonstrated that organoid responses to a combination of therapies matched response predictions from biomarker and clinical trial data, and subtype drug screening identified candidate therapies to optimize treatment for individual patients.

Funder: DF/HCC Breast SPORE

NRG Oncology adds new leadership members to Clinical Research Associate and Mentorship Subcommittees, Translational Science Committee

NRG Oncology
Business Announcement

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees.

Study uncovers pre-cancerous link between air pollution exposure and lung cancer risk

Emory University
Peer-Reviewed Publication

A new study—led by researchers at the American Cancer Society and Emory University’s Rollins School of Public Health—found molecular signs of changes in the blood of people who had been exposed to air pollution that were detectable several years before participants were diagnosed with lung cancer.

Journal: Nature Communications

Why some gastric tumors resist immunotherapy — and how macrophages tip the balance?

Science China Press
Peer-Reviewed Publication

Researchers identified two opposing tumor-associated macrophage states that regulate T cell interferon signaling and immunotherapy response in gastric cancer. An interferon-responsive immune niche predicts improved outcomes, while lipid-driven macrophages suppress T cell function and contribute to resistance.

Journal: Science Bulletin

Differences in immune cells predict skin cancer treatment outcomes

King's College London
Peer-Reviewed Publication

In a first-of-its-kind study by King’s College London, changes in two major types of immune cells in blood have been linked to different survival outcomes for patients with melanoma. Melanoma, the fifth most common cancer in the UK, is one of the deadliest forms of skin cancer, but is highly treatable when caught early.

Journal: Journal for ImmunoTherapy of Cancer

Tiny bacterial vesicles could help shape precision cancer treatment

KeAi Communications Co., Ltd.
Peer-Reviewed Publication

Bacteria naturally release microscopic particles known as bacterial extracellular vesicles. This review considers how these vesicles could be adapted for precision cancer medicine, from carrying drugs and activating immune responses to limiting metastasis and identifying cancer biomarkers. It also examines the practical obstacles ahead, including inconsistent production, safety risks, contamination and the lack of shared manufacturing and quality standards.

Journal: Biomedical Technology
Funder: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Shandong Provincial Education Department Project, Young Talent of Lifting Engineering for Science and Technology in Shandong, Foundation of National Center for Translational Medicine (Shanghai) SHU Branch, China International Medical Foundation Project, Hong Kong Scholar Program, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Collaborative Academic Innovation Project of Shandong Cancer Hospital, Hong Kong Research Grants Council, the funding support from “Laboratory for Synthetic Chemistry and Chemical Biology” under the Health@InnoHK Program launched by Innovation and Technology Commission, HKSAR.

SKKU researchers develop world’s first oral microbiome-based nanomedicine to supercharge anti-cancer immunity

Sungkyunkwan University External Affairs Division (PR team)
Peer-Reviewed Publication

Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy

Journal: Nature Nanotechnology

Trk and IGF1R-related signaling linked to delayed Ewing sarcoma growth

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – August 10, 2026 – A new research paper was published in Volume 17 of Oncotarget on August 7, 2026, titled “Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers.”

Journal: Oncotarget

Study finds traditional prostate cancer risk factors do not predict hormone therapy benefit

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A new UCLA study found that while traditional pathological features used to classify aggressive prostate cancer —such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles— after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy to postoperative radiation.

Journal: European Urology

UChicago Medicine Comprehensive Cancer Center partners with Lilly to expand clinical trial access

University of Chicago Medical Center
Business Announcement

The University of Chicago Medicine Comprehensive Cancer Center (UCCCC) and Eli Lilly and Company (Lilly) have partnered to help patients gain greater access to potential cancer treatments by participating in clinical trials.

87
88
89
90
91